JPRN-C000000230已完成2 期
Effects of pioglitazone on coronary atherosclerotic plaques of patients with impaired glucose tolerance or type 2 diabetes mellitus:a randomized,open rabelled,prospective study. - Effects of pioglitazone on coronary atherosclerotic plaques:a randomized,open rabelled,prospective study of Pioglitazone Intervention on Coronary Atherosclerosis (PIGEON) using intravascular ultrasound.
Chiba University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2005年12月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
Published: Nakayama T, Komiyama N, Yokoyama M, Namikawa S, Kuroda N, Kobayashi Y, Komuro I. Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: a randomized prospective study using intravascular ultrasound. Int J Cardiol. 2010;138(2):157-165. Epub 2008 Sep 24.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Heart failure,acute myocardial infarction,severe hepatic or renal dysfunction,to take insulin,already to take pioglitazone,episode of adverse effect by troglitazone,pregnancy and severe hypercholesterolemia.
研究者
相似试验
尚未招募
不适用
The effect of Pioglitazone in arteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose toleranceArteriosclerosis obliterans(ASO) patients with type 2 diabetes mellitus or impaired glucose toleranceJPRN-UMIN000005057Sanda City Hospital40
已完成
2 期
Pioglitazone Intervention for Coronary Atherosclerosis in Patients with Acute Coronary Syndrome.Acute coronary syndromeJPRN-C000000344Department of Cardiovascular Medicine Saitama Medical University International Medical Center100
已完成
2 期
Pioglitazone Intervention for Coronary Atherosclerosis in Patients with Metabolic Syndrome.Coronary atherosclerosis Metabolic syndromeJPRN-C000000332Department of Cardiovascular Medicine Saitama Medical University International Medical Center100
已完成
不适用
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 DiabetesHypertensionDyslipidemiaType 2 DiabetesDiabetic NephropathyNCT00419484Dokkyo Medical University1,000
已完成
4 期
Effect of Pioglitazone on TIMP-3 and TACE in Type 2 DiabetesType 2 DiabetesNCT01223196The University of Texas Health Science Center at San Antonio60